Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare carcinoma that arises from the larynx. It is characterized by the presence of small neuroendocrine cells. It metastasizes early and has an aggressive clinical course.
Biomarker and diagnostic research for laryngeal small cell carcinoma has been reported in the published literature.
No clinical trials have been registered for laryngeal small cell carcinoma.
31 publications have been identified in PubMed for laryngeal small cell carcinoma. Research spans Case Report / Case Series (34%), Review / Meta-Analysis (21%), and Diagnostic / Biomarker (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 34% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:56 PM UTC
6 |
21% |
Testing and diagnosis research | 5 | 17% |
Laboratory research | 4 | 14% |
Clinical study results | 2 | 7% |
Other research | 1 | 3% |
New treatment approaches | 1 | 3% |
Shen Y (2026). [PMID: 41203580](https://pubmed.ncbi.nlm.nih.gov/41203580/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Mladenovic N (2026). [PMID: 41969617](https://pubmed.ncbi.nlm.nih.gov/41969617/). *Case Rep Pathol*. [Case Report / Case Series]
Schnellhardt S (2026). [PMID: 41701314](https://pubmed.ncbi.nlm.nih.gov/41701314/). *Strahlenther Onkol*. [Other]
Rodrigo JP (2026). [PMID: 41594212](https://pubmed.ncbi.nlm.nih.gov/41594212/). *Diagnostics (Basel)*. [Review / Meta-Analysis]
Rajgor A (2026). [PMID: 41595157](https://pubmed.ncbi.nlm.nih.gov/41595157/). *Cancers (Basel)*. [Review / Meta-Analysis]
Nanda SS (2025). [PMID: 40436898](https://pubmed.ncbi.nlm.nih.gov/40436898/). *Sci Rep*. [Clinical Trial Publication]
Mu S (2025). [PMID: 39960929](https://pubmed.ncbi.nlm.nih.gov/39960929/). *Medicine (Baltimore)*. [Case Report / Case Series]
Zhao W (2025). [PMID: 41425253](https://pubmed.ncbi.nlm.nih.gov/41425253/). *Cancer Drug Resist*. [Review / Meta-Analysis]
Fu ZM (2025). [PMID: 39580588](https://pubmed.ncbi.nlm.nih.gov/39580588/). *Cancer Gene Ther*. [Basic Science / Preclinical]
Raponi I (2025). [PMID: 40585940](https://pubmed.ncbi.nlm.nih.gov/40585940/). *J Surg Case Rep*. [Case Report / Case Series]